6:24 PM
 | 
May 08, 2012
 |  BC Extra  |  Company News

Teva names Hayden CSO

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) hired Michael Hayden as CSO and president of global R&D. Hayden is currently a professor of medical genetics at the University of British Columbia and...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >